191 related articles for article (PubMed ID: 1901345)
1. Isolation and characterization of an apoA-II-containing lipoprotein (LP-A-II:B complex) from plasma very low density lipoproteins of patients with Tangier disease and type V hyperlipoproteinemia.
Alaupovic P; Knight-Gibson C; Wang CS; Downs D; Koren E; Brewer HB; Gregg RE
J Lipid Res; 1991 Jan; 32(1):9-19. PubMed ID: 1901345
[TBL] [Abstract][Full Text] [Related]
2. Studies on the mechanism of hypertriglyceridemia in Tangier disease. Determination of plasma lipolytic activities, k1 values and apolipoprotein composition of the major lipoprotein density classes.
Wang CS; Alaupovic P; Gregg RE; Brewer HB
Biochim Biophys Acta; 1987 Jul; 920(1):9-19. PubMed ID: 3109493
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein A-I Milano: sex-related differences in the concentration and composition of apoA-I- and apoB-containing lipoprotein particles.
Bekaert ED; Alaupovic P; Knight-Gibson CS; Franceschini G; Sirtori CR
J Lipid Res; 1993 Jan; 34(1):111-23. PubMed ID: 8445335
[TBL] [Abstract][Full Text] [Related]
4. Lipolytic degradation of human very low density lipoproteins by human milk lipoprotein lipase: the identification of lipoprotein B as the main lipoprotein degradation product.
Alaupovic P; Wang CS; McConathy WJ; Weiser D; Downs D
Arch Biochem Biophys; 1986 Jan; 244(1):226-37. PubMed ID: 3080947
[TBL] [Abstract][Full Text] [Related]
5. Lipoprotein ApoC-II activation of lipoprotein lipase. Modulation by apolipoprotein A-IV.
Goldberg IJ; Scheraldi CA; Yacoub LK; Saxena U; Bisgaier CL
J Biol Chem; 1990 Mar; 265(8):4266-72. PubMed ID: 2307668
[TBL] [Abstract][Full Text] [Related]
6. Metabolism of apolipoprotein B-100 and of triglyceride-rich lipoprotein particles in the absence of functional lipoprotein lipase.
Pacy PJ; Mitropoulos KA; Venkatesan S; Watts GF; Reeves BE; Halliday D
Atherosclerosis; 1993 Nov; 103(2):231-43. PubMed ID: 8292098
[TBL] [Abstract][Full Text] [Related]
7. Effect of heparin-induced lipolysis on the distribution of apolipoprotein e among lipoprotein subclasses. Studies with patients deficient in hepatic triglyceride lipase and lipoprotein lipase.
Rubinstein A; Gibson JC; Paterniti JR; Kakis G; Little A; Ginsberg HN; Brown WV
J Clin Invest; 1985 Feb; 75(2):710-21. PubMed ID: 3973025
[TBL] [Abstract][Full Text] [Related]
8. Properties of the plasma very low and low density lipoproteins in Tangier disease.
Heinen RJ; Herbert PN; Fredrickson DS
J Clin Invest; 1978 Jan; 61(1):120-32. PubMed ID: 201668
[TBL] [Abstract][Full Text] [Related]
9. Isolation and partial characterization of lipoprotein A-II (LP-A-II) particles of human plasma.
Bekaert ED; Alaupovic P; Knight-Gibson C; Norum RA; Laux MJ; Ayrault-Jarrier M
Biochim Biophys Acta; 1992 Jun; 1126(1):105-13. PubMed ID: 1606170
[TBL] [Abstract][Full Text] [Related]
10. Metabolism of apolipoprotein A-II containing triglyceride rich ApoB lipoproteins in humans.
Desai NK; Ooi EM; Mitchell PD; Furtado J; Sacks FM
Atherosclerosis; 2015 Aug; 241(2):326-33. PubMed ID: 26071654
[TBL] [Abstract][Full Text] [Related]
11. Lipoprotein particle abnormalities and the impaired lipolysis in renal insufficiency.
Lee DM; Knight-Gibson C; Samuelsson O; Attman PO; Wang CS; Alaupovic P
Kidney Int; 2002 Jan; 61(1):209-18. PubMed ID: 11786103
[TBL] [Abstract][Full Text] [Related]
12. Identification and partial characterization of discrete apolipoprotein B containing lipoprotein particles produced by human hepatoma cell line HepG2.
Dashti N; Alaupovic P; Knight-Gibson C; Koren E
Biochemistry; 1987 Jul; 26(15):4837-46. PubMed ID: 2822101
[TBL] [Abstract][Full Text] [Related]
13. Plasma lipoprotein composition in alcoholic hepatitis: accumulation of apolipoprotein E-rich high density lipoprotein and preferential reappearance of "light'-HDL during partial recovery.
Weidman SW; Ragland JB; Sabesin SM
J Lipid Res; 1982 May; 23(4):556-69. PubMed ID: 7097121
[TBL] [Abstract][Full Text] [Related]
14. Characterization of apoA- and apoB-containing lipoprotein particles in a variant of familial apoA-I deficiency with planar xanthoma: the metabolic significance of LP-A-II particles.
Bekaert ED; Alaupovic P; Knight-Gibson CS; Laux MJ; Pelachyk JM; Norum RA
J Lipid Res; 1991 Oct; 32(10):1587-99. PubMed ID: 1797940
[TBL] [Abstract][Full Text] [Related]
15. Studies of a variant very-low-density lipoprotein with an acquired deficiency of apolipoprotein C-II.
Reckless JP; Stocks J; Holdsworth G; Galton DJ; Suggett AJ; Walton KW
Clin Sci (Lond); 1982 Jan; 62(1):93-100. PubMed ID: 7056035
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of lipoproteins and apolipoproteins in serum of a Tangier patient by micro-scale two-dimensional electrophoresis.
Manabe T; Visvikis S; Dumon MF; Clerc M; Siest G
Clin Chem; 1987 Apr; 33(4):468-72. PubMed ID: 3103952
[TBL] [Abstract][Full Text] [Related]
17. Role of apolipoprotein E in the lipolytic conversion of beta-very low density lipoproteins to low density lipoproteins in type III hyperlipoproteinemia.
Ehnholm C; Mahley RW; Chappell DA; Weisgraber KH; Ludwig E; Witztum JL
Proc Natl Acad Sci U S A; 1984 Sep; 81(17):5566-70. PubMed ID: 6591204
[TBL] [Abstract][Full Text] [Related]
18. In vitro transformation of apoA-I-containing lipoprotein subpopulations: role of lecithin:cholesterol acyltransferase and apoB-containing lipoproteins.
Cheung MC; Wolf AC
J Lipid Res; 1989 Apr; 30(4):499-509. PubMed ID: 2502592
[TBL] [Abstract][Full Text] [Related]
19. Tangier disease. High density lipoprotein deficiency due to defective metabolism of an abnormal apolipoprotein A-i (ApoA-ITangier).
Schaefer EJ; Kay LL; Zech LA; Brewer HB
J Clin Invest; 1982 Nov; 70(5):934-45. PubMed ID: 7130397
[TBL] [Abstract][Full Text] [Related]
20. Effects of extended-release niacin on the postprandial metabolism of Lp(a) and ApoB-100-containing lipoproteins in statin-treated men with type 2 diabetes mellitus.
Ooi EM; Watts GF; Chan DC; Pang J; Tenneti VS; Hamilton SJ; McCormick SP; Marcovina SM; Barrett PH
Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2686-93. PubMed ID: 26515419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
